0
     

Report Added
Report already added
Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024

Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024

Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the BRIC pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $233.0 billion in 2019. Russia was the fastest growing country with a CAGR of 9.9% over the 2015-19 period.
- Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $142.6 billion in 2019. This was followed by India, Brazil and Russia with a value of $32.5, $29.6, and $28.4 billion, respectively.
- China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $206.3 billion in 2024, followed by India, Brazil, Russia with expected values of $38.6, $35.7 and $35.1 billion, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
- Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country

Reasons to Buy

- What was the size of the BRIC pharmaceuticals market by value in 2019?
- What will be the size of the BRIC pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the BRIC pharmaceuticals market?

Table of Contents
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 BRIC Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Brazil
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Pharmaceuticals in China
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 Pharmaceuticals in India
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Pharmaceuticals in Russia
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Company Profiles
7.1. Sanofi SA
7.2. EMS Sigma Pharma
7.3. Ache Laboratorios Farmaceuticos SA
7.4. Yangtze River Pharmaceutical Group
7.5. Shanghai Pharmaceutical Co Ltd
7.6. Guangzhou Pharmaceuticals Corp
7.7. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
7.8. Lupin Ltd
7.9. Sun Pharmaceutical Industries Inc
7.10. Dr. Reddy's Laboratories Limited
7.11. Aurobindo Pharma Ltd
7.12. Bayer AG
7.13. Novartis AG
7.14. Les Laboratoires Servier
8 Appendix
8.1. Methodology
8.2. About MarketLine

List of Tables
Table 1: BRIC pharmaceuticals industry, revenue($bn), 2015-24
Table 2: BRIC pharmaceuticals industry, revenue($bn), 2015-19
Table 3: BRIC pharmaceuticals industry, revenue($bn), 2019-24
Table 4: Brazil pharmaceuticals market value: $ billion, 2015-19
Table 5: Brazil pharmaceuticals market geography segmentation: $ billion, 2019
Table 6: Brazil pharmaceuticals market share: % share, by value, 2019
Table 7: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Table 8: Brazil size of population (million), 2015-19
Table 9: Brazil gdp (constant 2005 prices, $ billion), 2015-19
Table 10: Brazil gdp (current prices, $ billion), 2015-19
Table 11: Brazil inflation, 2015-19
Table 12: Brazil consumer price index (absolute), 2015-19
Table 13: Brazil exchange rate, 2015-19
Table 14: China pharmaceuticals market value: $ billion, 2015-19
Table 15: China pharmaceuticals market geography segmentation: $ billion, 2019
Table 16: China pharmaceuticals market share: % share, by value, 2019
Table 17: China pharmaceuticals market value forecast: $ billion, 2019-24
Table 18: China size of population (million), 2015-19
Table 19: China gdp (constant 2005 prices, $ billion), 2015-19
Table 20: China gdp (current prices, $ billion), 2015-19
Table 21: China inflation, 2015-19
Table 22: China consumer price index (absolute), 2015-19
Table 23: China exchange rate, 2015-19
Table 24: India pharmaceuticals market value: $ billion, 2015-19
Table 25: India pharmaceuticals market geography segmentation: $ billion, 2019
Table 26: India pharmaceuticals market share: % share, by value, 2019
Table 27: India pharmaceuticals market value forecast: $ billion, 2019-24
Table 28: India size of population (million), 2015-19
Table 29: India gdp (constant 2005 prices, $ billion), 2015-19
Table 30: India gdp (current prices, $ billion), 2015-19
Table 31: India inflation, 2015-19
Table 32: India consumer price index (absolute), 2015-19
Table 33: India exchange rate, 2015-19
Table 34: Russia pharmaceuticals market value: $ billion, 2015-19
Table 35: Russia pharmaceuticals market geography segmentation: $ billion, 2019
Table 36: Russia pharmaceuticals market share: % share, by value, 2019
Table 37: Russia pharmaceuticals market value forecast: $ billion, 2019-24
Table 38: Russia size of population (million), 2015-19
Table 39: Russia gdp (constant 2005 prices, $ billion), 2015-19
Table 40: Russia gdp (current prices, $ billion), 2015-19
Table 41: Russia inflation, 2015-19
Table 42: Russia consumer price index (absolute), 2015-19
Table 43: Russia exchange rate, 2015-19
Table 44: Sanofi SA: key facts
Table 45: Sanofi SA: Annual Financial Ratios
Table 46: Sanofi SA: Key Employees
Table 47: Sanofi SA: Key Employees Continued
Table 48: EMS Sigma Pharma: key facts
Table 49: EMS Sigma Pharma: Key Employees
Table 50: Ache Laboratorios Farmaceuticos SA: key facts
Table 51: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 52: Yangtze River Pharmaceutical Group: key facts
Table 53: Yangtze River Pharmaceutical Group: Key Employees
Table 54: Shanghai Pharmaceutical Co Ltd: key facts
Table 55: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 56: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 57: Guangzhou Pharmaceuticals Corp: key facts
Table 58: Guangzhou Pharmaceuticals Corp: Key Employees
Table 59: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd: key facts

List of Figures
Figure 1: BRIC pharmaceuticals industry, revenue($bn), 2015-24
Figure 2: BRIC pharmaceuticals industry, revenue($bn), 2015-19
Figure 3: BRIC pharmaceuticals industry, revenue($bn), 2019-24
Figure 4: Brazil pharmaceuticals market value: $ billion, 2015-19
Figure 5: Brazil pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 6: Brazil pharmaceuticals market share: % share, by value, 2019
Figure 7: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
Figure 8: Forces driving competition in the pharmaceuticals market in Brazil, 2019
Figure 9: Drivers of buyer power in the pharmaceuticals market in Brazil, 2019
Figure 10: Drivers of supplier power in the pharmaceuticals market in Brazil, 2019
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2019
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2019
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2019
Figure 14: China pharmaceuticals market value: $ billion, 2015-19
Figure 15: China pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 16: China pharmaceuticals market share: % share, by value, 2019
Figure 17: China pharmaceuticals market value forecast: $ billion, 2019-24
Figure 18: Forces driving competition in the pharmaceuticals market in China, 2019
Figure 19: Drivers of buyer power in the pharmaceuticals market in China, 2019
Figure 20: Drivers of supplier power in the pharmaceuticals market in China, 2019
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2019
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2019
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in China, 2019
Figure 24: India pharmaceuticals market value: $ billion, 2015-19
Figure 25: India pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 26: India pharmaceuticals market share: % share, by value, 2019
Figure 27: India pharmaceuticals market value forecast: $ billion, 2019-24
Figure 28: Forces driving competition in the pharmaceuticals market in India, 2019
Figure 29: Drivers of buyer power in the pharmaceuticals market in India, 2019
Figure 30: Drivers of supplier power in the pharmaceuticals market in India, 2019
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2019
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2019
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in India, 2019
Figure 34: Russia pharmaceuticals market value: $ billion, 2015-19
Figure 35: Russia pharmaceuticals market geography segmentation: % share, by value, 2019
Figure 36: Russia pharmaceuticals market share: % share, by value, 2019
Figure 37: Russia pharmaceuticals market value forecast: $ billion, 2019-24
Figure 38: Forces driving competition in the pharmaceuticals market in Russia, 2019
Figure 39: Drivers of buyer power in the pharmaceuticals market in Russia, 2019
Figure 40: Drivers of supplier power in the pharmaceuticals market in Russia, 2019
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2019
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2019
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2019

Kindly Fill The Form Below

Report Title: Pharmaceuticals BRIC (Brazil, Russia, India, China) Industry Guide 2015-2024


Valid Invalid number

Companies Covered
Ache Laboratorios Farmaceuticos SA
Aurobindo Pharma Ltd
Bayer AG
Dr. Reddy's Laboratories Limited
EMS Sigma Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Guangzhou Pharmaceuticals Corp
Les Laboratoires Servier
Lupin Ltd
Novartis AG
Sanofi SA
Shanghai Pharmaceutical Co Ltd
Sun Pharmaceutical Industries Inc
Yangtze River Pharmaceutical Group

SELECT A FORMAT

ADD TO CART BUY NOW